Animal Drug Companies Took Compounding Concerns ot FDA Before Adverse Events in Horses

Animal Drug Companies Took Compounding Concerns To FDA Before Incident

Drug companies met with FDA almost a month before compounded animal drugs were tied to adverse events in horses, with companies voicing concerns about FDA's lack of compounding enforcement on the animal front, an industry source said.

subscription required here